ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paganin, F.
Right arrow Articles by Yvin, J-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paganin, F.
Right arrow Articles by Yvin, J-L.
Eur Respir J 2004; 24:779-785
Copyright ©ERS Journals Ltd 2004

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

F. Paganin1,4, F. Lilienthal1,5, A. Bourdin1, N. Lugagne2, F. Tixier1, R. Génin3 and J-L. Yvin3

1 Service de Réanimation, 2 Service de Bactériologie, and 3 Service de Médecine Interne, Centre Hospitalier Departmental Félix Guyon, St Denis de la Réunion, and 4 Service de Pneumologie et Maladies Infectieuses, Groupe Hospitalier Sud Reunion (GHSR) St Pierre, Réunion, France. 5 Johnson & Johnson, Ranitan, NJ, USA.

CORRESPONDENCE: F. Paganin, Service de Pneumologie et Maladies Infectieuses, GHSR, BP 350, St Pierre, Réunion, France. Fax: 262 262359128. E-mail: f.paganin@wanadoo.fr

Keywords: Community-acquired pneumonia, intensive care unit, Klebsiella pneumoniae, mortality, prognosis, risk factors

Received: October 25, 2003
Accepted June 17, 2004

Community-acquired pneumonia (CAP) remains a major cause of mortality. The aetiology of CAP has rarely been identified as a mortality risk factor. A prospective study was conducted to assess the prognostic factors of CAP patients admitted to the intensive care unit (Centre Hospitalier Departmental Félix Guyon, St Denis de la Réunion, France), with a special emphasis on microbial aetiology.

All variables assessing severity were collected, with a special emphasis on microbial investigations. Among 112 immunocompetent patients (mean±SD age 54.7±15.1 yrs), 84% were male. Severity of CAP was demonstrated by mortality rate (43%), shock (48%), simplified acute physiology score (SAPS; 46.4±21.6) and mechanical ventilation support (82%). Mean risk factor score was 2.2±1.2. Microbiological identification was obtained in 78.6% of cases, with positive blood culture in 33%. Most frequently, microbial agents were Streptococcus pneumoniae and Klebsiella pneumoniae (42% and 22%, respectively).

The univariate analysis recorded the usual mortality variables: age, alcohol consumption, SAPS, shock, mechanical ventilation, positive end expiratory pressure level, positive blood culture, multilobar infiltrates on chest radiograph, neutropenia, and acidosis, and found K. pneumoniae (versus S. pneumoniae, and all CAP) as a mortality factor. The multivariate analysis demonstrated that septic shock (relative risk (RR) 141), K. pneumoniae CAP (RR 27), SAPS (RR 10.7) and positive blood culture (RR 2.7) were independent factors related to death.

In conclusion, the present study found that the microbial aetiology, Klebsiella pneumoniae, was an independent risk factor for mortality in severe community-acquired pneumonia.




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
L. B. Gadkowski and J. E. Stout
Cavitary Pulmonary Disease
Clin. Microbiol. Rev., April 1, 2008; 21(2): 305 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. W. Jenney, A. Clements, J. L. Farn, O. L. Wijburg, A. McGlinchey, D. W. Spelman, T. L. Pitt, M. E. Kaufmann, L. Liolios, M. B. Moloney, et al.
Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and Its Implications for Vaccine Development
J. Clin. Microbiol., January 1, 2006; 44(1): 102 - 107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.